Detalhe da pesquisa
1.
Cardiometabolic risk management: insights from a European Society of Cardiology Cardiovascular Round Table.
Eur Heart J
; 44(39): 4141-4156, 2023 Oct 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37448181
2.
Early Risks of Death, Stroke/Systemic Embolism, and Major Bleeding in Patients With Newly Diagnosed Atrial Fibrillation.
Circulation
; 139(6): 787-798, 2019 02 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30586740
3.
Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI.
N Engl J Med
; 375(25): 2423-2434, 2016 12 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-27959713
4.
Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry.
Eur Heart J
; 39(6): 464-473, 2018 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29281086
5.
Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy.
Circulation
; 135(4): 323-333, 2017 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-27881555
6.
Safety and efficacy of non-vitamin K oral anticoagulant for atrial fibrillation patients after percutaneous coronary intervention: A bivariate analysis of the PIONEER AF-PCI and RE-DUAL PCI trial.
Am Heart J
; 203: 17-24, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30015064
7.
Outcomes after catheter ablation and cardioversion in patients with non-valvular atrial fibrillation: results from the prospective, observational XANTUS study.
Europace
; 20(6): e87-e95, 2018 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29016755
8.
Total bleeding with rivaroxaban versus warfarin in patients with atrial fibrillation receiving antiplatelet therapy after percutaneous coronary intervention.
J Thromb Thrombolysis
; 46(3): 346-350, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29943350
9.
XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation.
Eur Heart J
; 37(14): 1145-53, 2016 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26330425
10.
Improving clinical trials for cardiovascular diseases: a position paper from the Cardiovascular Round Table of the European Society of Cardiology.
Eur Heart J
; 37(9): 747-54, 2016 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26077039
11.
Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF).
Am Heart J
; 178: 126-34, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27502860
12.
Patient-reported treatment satisfaction and budget impact with rivaroxaban vs. standard therapy in elective cardioversion of atrial fibrillation: a post hoc analysis of the X-VeRT trial.
Europace
; 18(2): 184-90, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26487668
13.
Rationale and design of a study exploring the efficacy of once-daily oral rivaroxaban (X-TRA) on the outcome of left atrial/left atrial appendage thrombus in nonvalvular atrial fibrillation or atrial flutter and a retrospective observational registry providing baseline data (CLOT-AF).
Am Heart J
; 169(4): 464-71.e2, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25819852
14.
An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin K antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary intervention (PIONEER AF-PCI).
Am Heart J
; 169(4): 472-8.e5, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25819853
15.
Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation.
Eur Heart J
; 35(47): 3346-55, 2014 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-25182247
16.
Rationale and design of the eXplore the efficacy and safety of once-daily oral riVaroxaban for the prEvention of caRdiovascular events in patients with nonvalvular aTrial fibrillation scheduled for cardioversion trial: A comparison of oral rivaroxaban once daily with dose-adjusted vitamin K antagonists in patients with nonvalvular atrial fibrillation undergoing elective cardioversion.
Am Heart J
; 167(5): 646-52, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24766973
17.
Healthcare Resource Utilization in Patients with Newly Diagnosed Atrial Fibrillation: A Global Analysis from the GARFIELD-AF Registry.
Healthcare (Basel)
; 11(5)2023 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36900643
18.
Stimulation of the AT2 receptor reduced atherogenesis in ApoE(-/-)/AT1A(-/-) double knock out mice.
J Mol Cell Cardiol
; 52(3): 630-7, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22230040
19.
Effect of dronedarone on cardiovascular events in atrial fibrillation.
N Engl J Med
; 360(7): 668-78, 2009 Feb 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-19213680
20.
Dronedarone in patients with congestive heart failure: insights from ATHENA.
Eur Heart J
; 31(14): 1717-21, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20436046